-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Zhaoke Ophthalmology-B (06622.HK) announced that on June 22, 2026, the company has acquired the global rights to NVK002 (atropine sulphate eye drops). NVK002 is a product designed to slow the deepening of myopia in children.

Zhitongcaijing·07/13/2026 08:57:10
Listen to the news
Zhitong Finance App News, Zhaoke Ophthalmology-B (06622.HK) announced that on June 22, 2026, the company has acquired the global rights to NVK002 (atropine sulphate eye drops). NVK002 is a product designed to slow the deepening of myopia in children.